why choose us

First received: October 09, 2023

Clinical Trial: A Retrospective Observational Study of Ustekinumab Among Bio-naive Participants With Crohn's Disease in China

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Crohn Disease

Study Type: OBSERVATIONAL


Official Title: A Multicenter, Retrospective, Observational Study Using Real-world Data to Describe the Effectiveness, Treatment Pattern and Safety of Ustekinumab Among Bio-naive Patients With Crohn's Disease in

Brief Summary: Bio-naive participants are defined as the participants who previously have not received any biologics for Crohn's Disease (CD).The purpose of this retrospective study is to describe the endoscopic remission at week 24 among bio-naive participants with CD treated with ustekinumab in China.

Read more